Skip to main content
SpringerLink
Log in

Synergy among agents inhibiting granulocyte aggregation

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Recent evidence suggests complement (C) -stimulated granulocytes (PMNs) are important in a variety of diseases, including shock and myocardial infarction (MI). Corticosteroids inhibit PMN response to C and show promise in some studies of shock and MI, but their use has not become routine for several reasons. Synergy was sought among agents inhibiting PMN aggregation in vitro in response to activated C: methylprednisolone (MP), with a 50% inhibitory dose (AD50) of 0.6 mg/ml; ibuprofen (IBU), with AD50 of 1.0 mg/ml, and betahistine (BH), with AD50 of 1.6 mg/ml. Simultaneous use of all three agents produced 3.4-fold synergy; 3-fold synergy obtained between IBU + MP and IBU + BH, while 1.5-fold synergy was noted between MP + BH. Further, MP and IBU were at least additive in inhibiting · O −2 a generation by FMLP-stimulated PMNs and in blocking directed migration. In a preliminary in vivo test of this finding, cats were given MP and IBU—in known individually ineffective doses—immediately prior to coronary artery ligation. Neither MP nor the low dose of IBU chosen limited the size of the resultant MI, while both agents together reduced MI size by 42%. Synergy among these agents suggests that they inhibit PMN function of distinct cellular mechanisms (as yet not elucidated). Further, early in vivo results encourage speculation that such synergy might ultimately be exploited clinically, although such speculation must presently be regarded as preliminary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jacob, H. S., P. R. Craddock, D. E. Hammerschmidt, andC. F. Moldow. 1980. Complement-induced granulocyte aggregation: An unsuspected mechanism of disease.N. Eng. J. Med. 302:789–794.

    Google Scholar 

  2. Redl, H., andG. Schlag. 1980. Morphologische Untersuchen der Lunge im Schock.In Anaesthesiologie und Intensivmedizin, Band 25, Kreislaufsschock. Springer-Verlag, Berlin.

    Google Scholar 

  3. Hosea, S., E. Brown, C. Hammer, andM. Frank. 1980. Role of complement activation in a model of adult respiratory distress syndrome.J. Clin. Invest. 66:375–382.

    Google Scholar 

  4. Hammerschmidt, D. E., L. J. Weaver, L. D. Hudson, P. R. Craddock, andH. S. Jacob. 1980. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome: Pathophysiologic relevance and possible prognostic value.Lancet 1:947–949.

    Google Scholar 

  5. Thakur, M. L., A. Gottschalk, andB. L. Zaret. 1979. Imaging experimental myocardial infarction with indium-111-labeled autologous leukocytes: Effects of infarct age and residual regional myocardial blood flow.Circulation 60:297–305.

    Google Scholar 

  6. Hill, J. A., andP. A. Ward. 1971. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats.J. Exp. Med. 133:885–900.

    Google Scholar 

  7. Lauter, C. B., M. R. El Khatib, J. A. Rising, andE. Robin. 1973. The nitrobluetetrazolium test in acute myocardial infarction.Ann. Intern. Med. 79:59–62.

    Google Scholar 

  8. Boyer, J. T., andR. A. O'Rourke. 1974. Consumption of classical complement by heart subcellular membranes in vitro and in patients after acute myocardial infarction.J. Clin. Invest. 56:740–750.

    Google Scholar 

  9. Hartmann, J., J. Robinson, andR. Gunnar. 1977. Chemotactic activity in the coronary sinus after experimental myocardial infarction: Effects of pharmacologie interventions on ischemic injury.Am. J. Cordial 40:550–555.

    Google Scholar 

  10. Hammerschmidt, D. E., J. G. White, P. R. Craddock, andH. S. Jacob. 1979. Corticosteroids inhibit complement-mediated granulocyte aggregation: A possible mechanism for their efficacy in shock states.J. Clin. Invest. 63:798–803.

    Google Scholar 

  11. White, G. L., L. T. Archer, B. K. Beller, andL. B. Hinshaw. 1978. Increased survival with methylprednisolone treatment in canine endotoxin shock.J. Surg. Res. 25:357–364.

    Google Scholar 

  12. Schumer, W. 1976. Steroids in the treatment of clinical septic shock.Ann. Surg. 184:333–341.

    Google Scholar 

  13. Sladen, A. 1976. Methylprednisolone. Pharmacologie doses in shock lung syndrome.J. Thorac. Cardiovasc. Surg. 21:800–805.

    Google Scholar 

  14. Joyce, L. D., J. M. Smith, H. G. Mauer, andR. C. Lillehei. 1979. Reduction of experimental myocardial infarct size by combined treatment with methylprednisolone sodium succinate and betahistine hydrochloride.Adv. Shock Res. 1:235–249.

    Google Scholar 

  15. Craddock, P. R., D. E. Hammerschmidt, J. G. White, A. P. Dalmasso, andH. S. Jacob. 1977. Complement (C5a)-induced granulocyte aggregation in vitro: A possible mechanism of complement-mediated leukostasis and leukopenia.J. Clin. Invest. 60:261–264.

    Google Scholar 

  16. Bøyum, A. 1968. Isolation of mononuclear cells and granulocytes from blood. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g.Scand. J. Lab. Invest. 21(Suppl. 97):77–89.

    Google Scholar 

  17. Zigmond, S. H., andJ. G. Hirsch. 1973. Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of cell-derived chemotactic factor.J. Exp. Med. 137:387.

    Google Scholar 

  18. Boyden, S. 1962. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes.J. Exp. Med. 115:453.

    Google Scholar 

  19. Weening, R. S., R. Wever, andD. Roos. 1975. Quantitative aspects of the production of Superoxide radicals by phagocytizing human granulocytes.J. Lab. Clin. Med. 85:245–252.

    Google Scholar 

  20. Craddock, P. R., D. E. Hammerschmidt, C. F. Moldow, O. Yamada, andH. S. Jacob. 1979. Granulocyte aggregation as a manifestation of membrane interactions with complement: Possible role in leukocyte margination, microvascular occlusion and endothelial damage.Sem. Haematol. 16:140–147.

    Google Scholar 

  21. Darsee, J. R., R. A. Kloner, andE. Braunwald. 1981. Demonstration of lateral and epicardial border zone salvage by flurbiprofen using an in vivo method for assessing myocardium at risk.Circulation 63:29–35.

    Google Scholar 

  22. Hunt, D. P., andR. J. Leigh. 1980. Overdose of ibuprofen causing unconsciousness and hypotension.Brit. Med. J. 281:1458.

    Google Scholar 

  23. Boots Pharmaceutical Co. Brufen 400: Pharmakologie und Klinische Erfahrung. Braumapharm Ges.m.b.H., Vienna, 1981. 34–35.

  24. Skubitz, K. M., P. R. Craddock, D. E. Hammerschmidt, andJ. T. August. 1981. Corticosteroids block binding of chemotactic peptide to its receptors on granulocytes and cause disaggregation of granulocyte aggregates in vitro.J. Clin. Invest. 68:13–20.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota

    Dale E. Hammerschmidt, Patrick J. Flynn, Patricia A. Coppo & Harry S. Jacob

  2. Departments of Medicine and of Pharmacology and Experimental Therapeutics, Johns Hopkins University School of Medicine, Baltimore, Maryland

    Keith M. Skubitz

Authors
  1. Dale E. Hammerschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick J. Flynn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricia A. Coppo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Keith M. Skubitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Harry S. Jacob
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Material presented in part to the plenary session of the 1981 annual meeting of the American Federation for Clinical Research, San Francisco, California.

Work supported in part by the following grants: N.I.H.(U.S.A.): AM-15730, CA-09243, HL-19725, HL-07062, HL-25043, HL-26218.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hammerschmidt, D.E., Flynn, P.J., Coppo, P.A. et al. Synergy among agents inhibiting granulocyte aggregation. Inflammation 6, 169–176 (1982). https://doi.org/10.1007/BF00916241

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00916241

Keywords

Search

Navigation